Oaktree Capital Group Holdings GP, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares (ADCT)

Filing Manager
Oaktree Capital Group Holdings GP, LLC
Reporting Manager
Oaktree Fund Administration, LLC
Security
ADC Therapeutics SA Common Shares
Symbol
ADCT
Shares outstanding
113M shares
Disclosed Ownership
4.67M shares
Ownership
4.14%
Form type
SCHEDULE 13G/A
Filing time
05 Nov 2025, 16:05:19 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oaktree Fund Administration, LLC 4.14% 4.67M 0 4.67M /s/ Henry Orren Henry Orren/ Senior Vice President
Oaktree Capital Holdings, LLC 4.14% 4.67M 0 4.67M /s/ Henry Orren Henry Orren/ Senior Vice President
Oaktree Capital Group Holdings GP, LLC 4.14% 4.67M 0 4.67M /s/ Henry Orren Henry Orren/ Senior Vice President
Brookfield Asset Management ULC 0% 0 0 0 /s/ Kathy Sarpash Kathy Sarpash/Managing Director, Legal & Regulatory
Brookfield Corporation 0% 0 0 0 /s/ Swati Mandava Swati Mandava/ Managing Director, Legal & Regulatory
Brookfield Asset Management, Ltd. 0% 0 0 0 /s/ Kathy Sarpash Kathy Sarpash/ Managing Director, Legal & Regulatory
BAM Partners Trust 0% 0 0 0 /s/ Kathy Sarpash Kathy Sarpash/Secretary